Immune response to stem cells and strategies to induce tolerance

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 362, Issue 1484, 2007, Pages 1343-1356

  Batten, Puspa ^a   Rosenthal, Nadia A ^a,b   Yacoub, Magdi H ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

Author keywords

Immune response; Regenerative medicine; Stem cells; Tissue engineering; Tolerance

Indexed keywords

BIOENGINEERING; IMMUNE RESPONSE; PHENOTYPE; TOLERANCE;

EID: 34547556266     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2007.2120     Document Type: Review

References (161)

1. Aggarwal, S. & Pittenger, M. F. 2004 Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815-1822. (doi:10.1182/blood-2004-04-1559)
2. Alvarez-Dolado, M., Pardal, R., Garcia-Verdugo, J. M., Fike, J. R., Lee, H. O., Pfeffer, K., Lois, C., Morrison, S. J. & Alvarez-Buylla, A. 2003 Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425, 968-973. (doi:10.1038/nature02069)
3. Amit, M., Shariki, C., Margulets, V. & Itskovitz-Eldor, J. 2004 Feeder layer- and serum-free culture of human embryonic stem cells. Biol. Reprod. 70, 837-845. (doi:10.1095/biolreprod.103.021147)
4. Andreadis, S. T. 2004 Gene transfer to epidermal stem cells: implications for tissue engineering. Expert Opin. Biol. Ther. 4, 783-800. (doi:10.1517/14712598.4.6.783)
5. Anversa, P., Leri, A. & Kajstura, J. 2006 Cardiac regeneration. J. Am. College Cardiol. 47, 1769-1776. (doi:10.1016/j.jacc.2006.02.003)
6. Askenasy, N., Yolcu, E. S., Yaniv, I. & Shirwan, H. 2005 Induction of tolerance using Fas ligand: a double-edged immunomodulator. Blood 105, 1396-1404. (doi:10.1182/blood-2004-06-2364)
7. Bani, D. 1997 Relaxin: a pleiotropic hormone. Gen. Pharmacol: The Vasc. Syst. 28, 13-22. (doi:10.1016/S0306-3623(96)00171-1)
8. Barber, C. L. & Iruela-Arispe, M. L. 2006 The ever-elusive endothelial progenitor cell: identities, functions and clinical implications. Pediatr. Res. 59, 26R-32R. (doi:10.1203/01.pdr.0000203553.46471. 18)
9. Barry, F. P. & Murphy, J. M. 2004 Mesenchymal stem cells: clinical applications and biological characterization. Int. J. Biochem. Cell Biol. 36, 568-584. (doi:10.1016/j.biocel.2003.11.001)
10. Bartholomew, A. et al. 2001 Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum. Gene Ther. 12, 1527-1541. (doi:10.1089/10430340152480258)
11. Bartholomew, A. et al. 2002 Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30, 42-48. (doi:10.1016/S0301-472X(01)00769-X)
12. Bathgate, R. A., Samuel, C. S., Burazin, T. C., Gundlach, A. L. & Tregear, G. W. 2003 Relaxin: new peptides, receptors and novel actions. Trends Endocrinol. Metab. 14, 207-213. (doi:10.1016/S1043-2760(03) 00081-X)
13. Batten, P., McCormack, A. M., Rose, M. L. & Yacoub, M. H. 2001 Valve interstitial cells induce donor-specific T-cell anergy. J. Thorac. Cardiovasc. Surg. 122, 129-135. (doi:10.1067/mtc.2001.114940)
14. Batten, P., Sarathchandra, P., Antoniw, J. W., Tay, S. S., Lowdell, M. W., Taylor, P. M. & Yacoub, M. H. 2006 Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the th2 pathway: relevance to tissue engineering human heart valves. Tissue Eng. 12, 2263-2273. (doi:10.1089/ten.2006.12.2263)
15. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A. & Duke, R. C. 1995 A role for CD95 ligand in preventing graft rejection. Nature 377, 630-632. (doi:10.1038/377630a0)
16. Beltrami, A. P. et al. 2003 Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763-776. (doi:10.1016/S0092-8674(03)00687-1)
17. Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Asian, H., Galun, E. & Rachmilewitz, J. 2005 Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105, 2214-2219. (doi:10.1182/blood-2004-07-2921)
18. Bin, Z., Sheng, L. G., Gang, Z.C, Hong, J., Jun, C., Bo, Y. & Hui, S. 2006 Efficient cardiomyocyte differentiation of embryonic stem cells by bone morphogenetic protein-2 combined with visceral endoderm-like cells. Cell Biol. Int. 30, 769-776. (doi:10.1016/j.cellbi.2006.05.011)
19. Boheler, K. R. & Fiszman, M. Y. 1999 Can exogenous stem cells be used in transplantation? Cells Tissues Organs 165, 237-245. (doi:10.1159/000016684)
20. Boyd, A. S., Higashi, Y. & Wood, K. J. 2005 Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. Adv. Drug Deliv. Rev. 57, 1944-1969. (doi:10.1016/j.addr.2005.08.004)
21. Bradley, J. A., Bolton, E. M. & Pedersen, R. A. 2002 Stem cell medicine encounters the immune system. Nat. Rev. Immunol. 2, 859-871. (doi:10.1038/nri934)
22. Braudeau, C., Bouchet, D., Tesson, L., Iyer, S., Remy, S., Buelow, R., Anegon, I. & Chauveau, C. 2004 Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther. 11, 701-710. (doi:10.1038/sj.gt.3302208)
23. Bryder, D., Rossi, D. J. & Weissman, I. L. 2006 Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am. J. Pathol. 169, 338-346. (doi:10.2353/ajpath.2006.060312)
24. Buell, J. F., Gross, T. G., Thomas, M. J., Neff, G., Muthiah, C., Alloway, R., Ryckman, F. C., Tiao, G. M. & Woodle, E. S. 2006 Malignancy in pediatric transplant recipients. Semin. Pediatr. Surg. 15, 179-187. (doi:10.1053/j.sem-pedsurg.2006.03.005)
25. Camara, N. O. & Soares, M. P. 2005 Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radic. Biol. Med. 38, 426-435. (doi:10.1016/j.freeradbiomed.2004.11.019)
26. Chauveau, C. et al. 2005 Heme oxygenase-1 expression inhibits dendritic cell maturation and pro-inflammatory function but conserves IL-10 expression. Blood 106, 1694-1702. (doi:10.1182/blood-2005-02-0494)
27. Chinzei, R. et al. 2002 Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes. Hepatology 36, 22-29. (doi:10.1053/jhep.2002.34136)
28. Choi, A. M. & Alam, J. 1996 Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell Mol. Biol. 15, 9-19.
29. Choi, R. S. & Vacanti, J. P. 1997 Preliminary studies of tissue-engineered intestine using isolated epithelial organoid units on tubular synthetic biodegradable scaffolds. Transpl. Proc. 29, 848-851. (doi:10.1016/S0041-1345(96)00164-9)
30. Clark, J. E., Naughton, P., Shurey, S., Green, C. J., Johnson, T. R., Mann, B. E., Foresti, R. & Motterlini, R. 2003 Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ. Res. 93, e2-e8. (doi:10.1161/01.RES.0000084381.86567.08)
31. Collins, L., Gustafsson, K. & Fabre, J. W. 2000a Tissue-binding properties of a synthetic peptide DNA vector targeted to cell membrane integrins: a possible universal nonviral vector for organ and tissue transplantation. Transplantation 69, 1041-1050. (doi:10.1097/00007890-200003270-00006)
32. Collins, L., Sawyer, G. J., Zhang, X. H., Gustafsson, K. & Fabre, J. W. 2000b In vitro investigation of factors important for the delivery of an integrin-targeted nonviral DNA vector in organ transplantation. Transplantation 69, 1168-1176. (doi:10.1097/00007890-200003270- 00023)
33. Corcione, A. et al. 2006 Human mesenchymal stem cells modulate B-cell functions. Blood 107, 367-372. (doi:10.1182/blood-2005-07- 2657)
34. Dawn, B. et al. 2005 Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc. Natl Acad. Sci. USA 102, 3766-3771. (doi:10.1073/pnas.0405957102)
35. De Ugarte, D. A. et al. 2003 Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174, 101-109. (doi:10.1159/000071150)
36. Devine, S. M. 2002 Mesenchymal stem cells: will they have a role in the clinic? J. Cell Biochem. Suppl. 38, 73-79. (doi:10.1002/jcb.10046)
37. Devine, S. M., Cobbs, C., Jennings, M., Bartholomew, A. & Hoffman, R. 2003 Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101, 2999-3001. (doi:10.1182/blood-2002-06-1830)
38. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S. & Gianni, A. M. 2002 Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or non-specific mitogenic stimuli. Blood 99, 3838-3843. (doi:10.1182/blood.V99.10. 3838)
39. Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noel, D. & Jorgensen, C. 2003 Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102, 3837-3844. (doi:10.1182/blood-2003-04-1193)
40. Draper, J. S., Pigott, C., Thomson, J. A. & Andrews, P. W. 2002 Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 200, 249-258. (doi:10.1046/j.1469-7580.2002. 00030.x)
41. Drukker, M. & Benvenisty, N. 2004 The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol. 22, 136-141. (doi:10.1016/j.tibtech.2004.01.003)
42. Drukker, M., Katz, G., Urbach, A., Schuldiner, M., Markel, G., Itskovitz-Eldor, J., Reubinoff, B., Mandelboim, O. & Benvenisty, N. 2002 Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl Acad. Sci. USA 99, 9864-9869. (doi:10.1073/pnas.142298299)
43. Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein, E., Mandelboim, O., Reisner, Y. & Benvenisty, N. 2006 Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24, 221-229. (doi:10.1634/stemcells.2005-0188)
44. Eisenberg, C. A. & Eisenberg, L. M. 1999 WNT11 promotes cardiac tissue formation of early mesoderm. Dev. Dyn. 216, 45-58. (doi:10.1002/(SICI)1097-0177(199909)216:1 〈45::AID-DVDY7〉 3.0.CO;2-L)
45. Eliopoulos, N., Stagg, J., Lejeune, L., Pommey, S. & Galipeau, J. 2005 Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 106, 4057-4065. (doi:10.1182/blood-2005-03-1004)
46. Ellerstrom, C., Strehl, R., Moya, K., Andersson, K., Bergh, C., Lundin, K., Hyllner, J. & Semb, H. 2006 Derivation of a xeno-free human ES cell line. Sum Cells 24, 2170-2176. (doi:10.1634/stemcells.2006-0130)
47. Evans, G. A. 1993 "MegaYAC" library. Science 260, 877. (doi:10.1126/science.8493512)
48. Fairchild, P. J., Cartland, S., Nolan, K. F. & Waldmann, H. 2004 Embryonic stem cells and the challenge of transplantation tolerance. Trends Immunol. 25, 465-470. (doi:10.1016/j.it.2004.07.005)
49. Fijnvandraat, A. C., van Ginneken, A. C., Schumacher, C. A., Boheler, K. R., Lekanne Deprez, R. H., Christoffels, V. M. & Moorman, A. F. 2003 Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium. J. Mol. Cell Cardiol. 35, 1461-1472. (doi:10.1016/j.yjmcc.2003.09.011)
50. Foresti, R., Hammad, J., Clark, J. E., Johnson, T. R., Mann, B. E., Friebe, A., Green, C. J. & Motterlini, R. 2004 Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br. J. Pharmacol. 142, 453-460. (doi:10.1038/sj.bjp.0705825)
51. Gage, F. H. 1998 Cell therapy. Nature 392, 18-24.
52. Granowitz, E. V., Clark, B. D., Mancilla, J. & Dinarello, C. A. 1991 Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J. Biol. Chem. 266, 14 147-14 150.
53. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R. & Ferguson, T. A. 1995 Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192. (doi:10.1126/science.270.5239. 1189)
54. Grinnemo, K. H. et al. 2004 Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J. Thorac. Cardiovasc. Surg. 127, 1293-1300. (doi:10.1016/j.jtcvs.2003. 07.037)
55. Grusby, M. J. & Glimcher, L. H. 1995 Immune responses in MHC class II-deficient mice. Annu. Rev. Immunol. 13, 417-435. (doi:10.1146/annurev.iy.13.040195.002221)
56. Guo, Y., Stein, A. B., Wu, W. J., Tan, W., Zhu, X., Li, Q. H., Dawn, B., Motterlini, R. &. Bolli, R. 2004 Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am. J. Physiol. Heart Circ. Physiol. 286, H1649-H1653. (doi:10.1152/ajpheart.00971. 2003)
57. Hierlihy, A. M., Seale, P., Lobe, C. G., Rudnicki, M. A. & Megeney, L. A. 2002 The post-natal heart contains a myocardial stem cell population. FEBS Lett. 530, 239-243. (doi:10.1016/S0014-5793(02)03477-4)
58. Hoerstrup, S. P. et al. 2002 Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 106, I143-I150.
59. Hori, J., Ng, T. F., Shatos, M., Klassen, H., Streilein, J. W. & Young, M. J. 2003 Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 21, 405-416. (doi:10.1634/stemcells.21-4-405)
60. Horwitz, E. M., Gordon, P. L., Koo, W. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L. & Hofmann, T. 2002 Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl Acad. Sci. USA 99, 8932-8937. (doi:10.1073/pnas.132252399)
61. Inoue, S., Popp, F. C., Koehl, G. E., Piso, P., Schlitt, H. J., Geissler, E. K. & Dahlke, M. H. 2006 Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81, 1589-1595. (doi:10.1097/01.tp.0000209919.90630.7b)
62. Ivell, R. & Einspanier, A. 2002 Relaxin peptides are new global players. Trends Endocrinol. Metab. 13, 343-348. (doi:10.1016/S1043-2760(02)00664-1)
63. Johnson, T. R., Mann, B. E., Clark, J. E., Foresti, R., Green, C. J. & Motterlini, R. 2003 Metal carbonyls: a new class of pharmaceuticals? Angew. Chem. Int. Edn. Engl. 42, 3722-3729. (doi:10.1002/anie. 200301634)
64. Kaihara, S., Borenstein, J., Koka, R., Lalan, S., Ochoa, E. R., Ravens, M., Pien, H., Cunningham, B. & Vacanti, J. P. 2000 Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng. 6, 105-117. (doi:10.1089/107632700320739)
65. Kajstura, J. et al. 2005 Bone marrow cells differentiate in cardiac cell lineages after infarction independendy of cell fusion. Circ. Res. 96, 127-137. (doi:10.1161/01.RES.0000151843.79801.60)
66. Katori, M., Busuttil, R. W. & Kupiec-Weglinski, J. W. 2002 Heme oxygenase-1 system in organ transplantation. Transplantation 74, 905-912. (doi:10.1097/00007890-200210150-00001)
67. Kehat, I. et al. 2004 Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22, 1282-1289. (doi:10.1038/nbt1014)
68. Klug, M. G., Soonpaa, M. H., Koh, G. Y. & Field, L. J. 1996 Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J. Clin. Invest. 98, 216-224.
69. Koc, O. N., Gerson, S. L., Cooper, B. W., Dyhouse, S. M., Haynesworth, S. E., Caplan, A. I. & Lazarus, H. M. 2000 Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 18, 307-316.
70. Koc, O. N., Day, J., Nieder, M., Gerson, S. L., Lazarus, H. M. & Krivit, W. 2002 Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 30, 215-222. (doi:10.1038/sj.bmt.1703650)
71. Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E. & Dazzi, F. 2003 Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101, 3722-3729. (doi:10.1182/blood-2002-07-2104)
72. Ku, C. H., Johnson, P. H., Batten, P., Sarathchandra, P., Chambers, R. C., Taylor, P. M., Yacoub, M. H. & Chester, A. H. 2006 Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc. Res. 71, 548-556. (doi:10.1016/j.cardiores.2006.03.022)
73. Lanza, R. P., Cibelli, J. B. & West, M. D. 1999 Prospects for the use of nuclear transfer in human transplantation. Nat. Biotechnol. 17, 1171-1174. (doi:10.1038/70709)
74. Latif, N. et al. Submitted. Human valve interstitial cells demonstrate transdifferentiation potential.
75. Laugwitz, K. L. et al. 2005 Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647-653. (doi:10.1038/nature03215)
76. Le Blanc, K. & Pittenger, M. 2005 Mesenchymal stem cells: progress toward promise. Cytotherapy. 7, 36-45. (doi:10.1080/ 14653240510018118)
77. Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E. & Ringden, O. 2003 HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 31, 890-896. (doi:10.1016/S0301-472X(03)00110-3)
78. Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M. & Ringden, O. 2004 Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441. (doi:10.1016/S0140-6736(04)16104-7)
79. Le Blanc, K. et al. 2005 Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79, 1607-1614. (doi:10.1097/01.TP.0000159029.48678.93)
80. Lee, J. B., Lee, J. E., Park, J. H., Kim, S. J., Kim, M. K., Roh, S. I. & Yoon, H. S. 2005 Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition. Biol. Reprod. 72, 42-49. (doi:10.1095/biolreprod.104.033480)
81. Li, Y., McCormack, A. M., Brand, N. J. & Yacoub, M. H. 2000 A strategy for inducing immune tolerance to valve endothelial cells through gene transfer. J. Heart Valve Dis. 9, 439-444.
82. Li, J., Collins, L., Zhang, X., Gustafsson, K. & Fabre, J. W. 2001 Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection. Transplant Proc. 33, 589-589. (doi:10.1016/S0041-1345(00)02155-2)
83. Liechty, K. W., MacKenzie, T. C., Shaaban, A. F., Radu, A., Moseley, A. M., Deans, R., Marshak, D. R. & Flake, A. W. 2000 Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat. Med. 6, 1282-1286. (doi:10.1038/81395)
84. Lim, S. Y. et al. 2006 The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc. Res. 70, 530-542. (doi:10.1016/j.cardiores.2006.02.016)
85. Linke, A. et al. 2005 Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl Acad. Sci. USA 102, 8966-8971. (doi:10.1073/pnas.0502678102)
86. Liu, J. et al. 2004 Suppression of human peripheral blood lymphocyte proliferation by immortalized mesenchymal stem cells derived from bone marrow of Banna Minipig inbred-line. Transplant Proc. 36, 3272-3275. (doi:10.1016/j.transproceed.2004.11.090)
87. Liu, H., Kemeny, D. M., Heng, B. C., Ouyang, H. W., Melendez, A. J. & Cao, T. 2006 The immunogenicity and immunomodulatory function of osteogenic cells differ-entiated from mesenchymal stem cells. J. Immunol. 176, 2864-2871.
88. Majumdar, M. K., Keane-Moore, M., Buyaner, D., Hardy, W. B., Moorman, M. A., McIntosh, K. R. & Mosca, J. D. 2003 Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J. Biomed. Sci. 10, 228-241. (doi:10.1007/BF02256058)
89. Mammolenti, M., Gajavelli, S., Tsoulfas, P. & Levy, R. 2004 Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro. Stem Cells 22, 1101-1110. (doi:10.1634/stemcells.22-6-1101)
90. Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S. & Dzau, V. J. 2003 Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9, 1195-1201. (doi:10.1038/nm912)
91. Martin, M. J., Muotri, A., Gage, F. & Varki, A. 2005 Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11, 228-232. (doi:10.1038/nm1181)
92. Martinez-Estrada, O. M., Munoz-Santos, Y., Julve, J., Reina, M. & Vilaro, S. 2005 Human adipose tissue as a source of Flk-1+ cells: new method of differentiation and expansion. Cardiovasc. Res. 65, 328-333. (doi:10.1016/j.cardiores.2004.11.015)
93. Matsui, T. et al. 2001 Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104, 330-335.
94. Matsuura, K. et al. 2004 Adult cardiac Sea-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem. 279, 11 384-11 391. (doi:10.1074/jbc.M310822200)
95. McCloskey, K. E., Gilroy, M. E. & Nerem, R. M. 2005 Use of embryonic stem cell-derived endothelial cells as a cell source to generate vessel structures in vitro. Tissue Eng. 11, 497-505. (doi:10.1089/ten. 2005.11.497)
96. McLaren, A. 2001 Ethical and social considerations of stem cell research. Nature 414, 129-131. (doi:10.1038/35102194)
97. McNerney, M. E. et al. 2006 Role of natural killer cell subsets in cardiac allograft rejection. Am. J. Transplant. 6, 505-513. (doi:10.1111/j.1600-6143.2005.01226.x)
98. Meisel, R., Zibert, A., Laryea, M., Gobel, U., Daubener, W. & Dilloo, D. 2004 Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103, 4619-4621. (doi:10.1182/blood-2003-11-3909)
99. Menard, C. et al. 2005 Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366, 1005-1012. (doi:10.1016/S0140-6736(05)67380-1)
100. Messina, E. et al. 2004 Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95, 911-921. (doi:10.1161/01.RES.0000147315.71699.51)
101. Meyer, N., Jaconi, M., Landopoulou, A., Fort, P. & Puceat, M. 2000 A fluorescent reporter gene as a marker for ventricular specification in ES-derived cardiac cells. FEBS Lett. 478, 151-158. (doi:10.1016/S0014-5793(00)01839-1)
102. Min, J. Y., Yang, Y., Converso, K. L., Liu, L., Huang, Q., Morgan, J. P. & Xiao, Y. F. 2002 Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 92, 288-296. (doi:10.1063/1.1481962)
103. Modino, S. A. C. & Sharpe, P. T. 2005 Tissue engineering of teeth using adult stem cells. Arch. Oral Biol. 50, 255-258. (doi:10.1016/j.archoralbio.2005.01.002)
104. Moretta, L., Bottino, C., Pende, D., Mingari, M. C., Biassoni, R. & Moretta, A. 2002 Human natural killer cells: their origin, receptors and function. Eur. J. Immunol. 32, 1205-1211. (doi:10.1002/1521- 4141(200205)32:5 〈1205::AID-IMMU1205〉 3.0.CO;2-Y)
105. Moretta, L., Romagnani, C., Pietra, G., Moretta, A. & Mingari, M. C. 2003 NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol. 24, 136-143. (doi:10.1016/S1471-4906(03)00031-0)
106. Mosca, J. D. et al. 2000 Mesenchymal stem cells as vehicles for gene delivery. Clin. Orthop. Relat. Res. 379, S71-S90. (doi:10.1097/00003086-200010001-00011)
107. Motterlini, R., Clark, J. E., Foresti, R., Sarathchandra, P., Mann, B. E. & Green, C. J. 2002 Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ. Res. 90, E17-E24. (doi:10.1161/hh0202.104530)
108. Muller, M. et al. 2000 Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J. 14, 2540-2548. (doi:10.1096/fj.00-0002com)
109. Mummery, C. et al. 2003 Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107, 2733-2740. (doi:10.1161/01.CIR.0000068356.38592. 68)
110. Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C. & Mellor, A. L. 1998 Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191-1193. (doi:10.1126/science.281.5380.1191)
111. Murtuza, B., Suzuki, K., Bou-Gharios, G., Beauchamp, J. R., Smolenski, R. T., Partridge, T. A. & Yacoub, M. H. 2004 Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc. Natl Acad. Sci. USA 101, 4216-4221. (doi:10.1073/pnas.0306205101)
112. Nadal-Ginard, B. & Fuster, V. 2007 Myocardial cell therapy at the crossroads. Nat. Clin. Pract. Cardiovasc. Med 4, 1. (doi:10.1038/ncpcardio0743)
113. Neuenschwander, S. & Hoerstrup, S. P. 2004 Heart valve tissue engineering. Transpl. Immunol. 12, 359-365. (doi:10.1016/j.trim. 2003.12.010)
114. Odorico, J. S., Kaufman, D. S. & Thomson, J. A. 2001 Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19, 193-204. (doi:10.1634/stemcells.19-3-193)
115. Oh, H. et al. 2003 Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA 100, 12 313-12 318. (doi:10.1073/pnas.2132126100)
116. Ott, C. H., Matthiesen, T. S., Brechtken, J., Xin, X., Barnes, S. A., Nelson, W., Goh, S.-K. & Taylor, D. A. 2005 A novel population of adult derived cardiac progenitor cells is capable of functional myocardial repair. Circulation 112, 11-51.
117. Pae, H. O., Oh, G. S., Choi, B. M., Chae, S. C., Kim, Y. M., Chung, K. R. & Chung, H. T. 2004 Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J. Immunol. 172, 4744-4751.
118. Pandur, P., Lasche, M., Eisenberg, L. M. & Kuhl, M. 2002 Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 418, 636-641. (doi:10.1038/nature00921)
119. Pang, Y., Cui, P., Chen, W., Gao, P. & Zhang, H. 2005 Quantitative study of tissue-engineered cartilage with human bone marrow mesenchymal stem cells. Arch. Facial Plast. Surg. 7, 7-11. (doi:10.1001/archfaci.7. 1.7)
120. Patel, S., Zhang, X., Collins, L. & Fabre, J. W. 2001 A small, synthetic peptide for gene delivery via the serpin-enzyme complex receptor. J. Gene Med. 3, 271-279. (doi:10.1002/jgm.180)
121. Perm, I. 2000 Post-transplant malignancy: the role of immunosuppression. Drug Saf. 23, 101-113. (doi:10.2165/00002018-200023020-00002)
122. Perin, E. C. et al. 2003 Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107, 2294-2302. (doi:10.1161/01.CIR.0000070596.30552. 8B)
123. Piccinni, M. P., Scaletti, C., Maggi, E. & Romagnani, S. 2000 Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy. J. Neuroimmunol. 109, 30-33. (doi:10.1016/S0165-5728(00)00299-X)
124. Pincock, S. 2004 Newcastle centre gains licence for therapeutic cloning. Br. Med. J. 329, 417-417. (doi:10.1136/bmj.329.7463.417)
125. Pittenger, M. F. & Martin, B. J. 2004 Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95, 9-20. (doi:10.1161/01.RES.0000135902.99383.6f)
126. Pittenger, M. F., Mosca, J. D. & McIntosh, K. R. 2000 Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma. Curr. Top. Microbiol. Immunol. 251, 3-11.
127. Planat-Benard, V., Menard, C., Andre, M., Puceat, M., Perez, A., Garcia-Verdugo, J. M., Penicaud, L. & Casteilla, L. 2004a Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ. Res. 94, 223-229. (doi:10.1161/01.RES.0000109792.43271.47)
128. Planat-Benard, V. et al. 2004b Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109, 656-663. (doi:10.1161/01.CIR. 0000114522.38265.61)
129. Poss, K. D. & Tonegawa, S. 1997a Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl Acad. Sci. USA 94, 10 919-10 924. (doi:10.1073/pnas.94.20.10919)
130. Poss, K. D. & Tonegawa, S. 1997b Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl Acad. Sci. USA 94, 10 925-10 930. (doi:10.1073/pnas.94.20.10925)
131. Potian, J. A., Aviv, H., Ponzio, N. M., Harrison, J. S. & Rameshwar, P. 2003 Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol. 171, 3426-3434.
132. Prockop, D. J., Gregory, C. A. & Spees, J. L. 2003 One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc. Natl Acad. Sci. USA 100(Suppl. 1), 11 917-11 923. (doi:10.1073/pnas.1834138100)
133. Richards, M., Fong, C. Y., Chan, W. K., Wong, P. C. & Bongso, A. 2002 Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat. Biotechnol. 20, 933-936. (doi:10.1038/nbt726)
134. Ruggeri, L., Capanni, M., Martelli, M. F. & Velardi, A. 2001 Cellular therapy: exploiting NK cell alloreactivity in transplantation. Curr. Opin. Hematol. 8, 355-359. (doi:10.1097/00062752-200111000-00007)
135. Ryan, J., Barry, F., Murphy, J. M. & Mahon, B. 2005 Mesenchymal stem cells avoid allogeneic rejection. J. Inflamm. 2, 8. (doi:10.1186/1476-9255-2-8)
136. Sanchez, P. L., San Roman, J. A., Villa, A., Fernandez, M. E. & Fernandez-Aviles, F. 2006 Contemplating the bright future of stem cell therapy for cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl. 1), S138-S151. (doi:10.1038/ncpcardio0456)
137. Sawle, P., Foresti, R., Mann, B. E., Johnson, T. R., Green, C. J. & Motterlini, R. 2005 Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br. J. Pharmacol. 145, 800-810. (doi:10.1038/sj.bjp. 0706241)
138. Sawle, P., Hammad, J., Fairlamb, I. J., Moulton, B., O'Brien, C. T., Lynam, J. M., Duhme-Klair, A. K., Foresti, R. & Motterlini, R. 2006 Bioactive properties of iron-containing carbon monoxide-releasing molecules (CORMs). J. Pharmacol. Exp. Ther. 318, 403-410. (doi:10.1124/jpet.106.101758)
139. Schek, R. M., Taboas, J. M., Hollister, S. J. & Krebsbach, P. H. 2005 Tissue engineering osteochondral implants for temporomandibular joint repair. Orthodont. Craniofac. Res. 8, 313-319. (doi:10.1111/j.1601-6343. 2005.00354.x)
140. Serakinci, N. & Keith, W. N. 2006 Therapeutic potential of adult stem cells. Eur. J. Cancer 42, 1243-1246. (doi:10.1016/j.ejca.2006.01. 036)
141. Simon, D. M. & Levin, S. 2001 Infectious complications of solid organ transplantations. Infect. Dis. Clin. North Am. 15, 521-549. (doi:10.1016/S0891-5520(05)70158-6)
142. Singer, G. G. & Abbas, A. K. 1994 The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365-371. (doi:10.1016/1074-7613(94) 90067-1)
143. Smits, A. M., van Vliet, P., Hassink, R. J., Goumans, M. J. & Doevendans, P. A. 2005 The role of stem cells in cardiac regeneration. J. Cell Mol. Med. 9, 25-36. (doi:10.1111/j.1582-4934.2005.tb00334.x)
144. Stamm, C., Kleine, H. D., Westphal, B., Petzsch, M., Kittner, C., Nienaber, C. A., Freund, M. & Steinhoff, G. 2004 CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac. Cardiovasc. Surg. 52, 152-158. (doi:10.1055/s-2004-817981)
145. Stock, U. A. & Vacanti, J. P. 2001 Tissue engineering: current state and prospects. Annu. Rev. Med. 52, 443-451. (doi:10.1146/annurev. med.52.1.443)
146. Strauer, B. E., Brehm, M., Zeus, T., Kostering, M., Hernandez, A., Sorg, R. V., Kogler, G. & Wernet, P. 2002 Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106, 1913-1918. (doi:10.1161/01.CIR.0000034046.87607. 1C)
147. Suzuki, K., Murtuza, B., Smolenski, R. T., Sammut, I. A., Suzuki, N., Kaneda, Y. & Yacoub, M. H. 2001 Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 104, I308-I3I3.
148. Swijnenburg, R. J. et al. 2005 Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112, I166-I172.
149. Tateishi, K., Takahashi, T., Nomura, T., Yamagishi, M., Yaku, H., Matsubara, H. & Oh, H. 2005 Single cardiac stem cells from adult mammalian heart are multipotent and can regenerate ischemic myocardium. Circulation 112, II-51.
150. Terami, H., Hidaka, K., Katsumata, T., Iio, A. & Morisaki, T. 2004 Wnt11 facilitates embryonic stem cell differentiation to Nkx2.5-positive cardiomyocytes. Biochem. Biophys. Res. Commun. 325, 968-975. (doi:10.1016/j.bbrc.2004.10.103)
151. Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J. & Kessler, P. D. 2002 Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98. (doi:10.1161/hc0102.101442)
152. Tse, W. T., Pendleton, J. D., Beyer, W. M., Egalka, M. C. & Guinan, E. C. 2003 Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389-397. (doi:10.1097/01.TP.0000045055.63901.A9)
153. Vaananen, H. K. 2005 Mesenchymal stem cells. Ann. Med. 37, 469-479. (doi:10.1080/07853890500371957)
154. Veinot, J. P., Prichett-Pejic, W., Song, J., Waghray, G., Parks, W., Mesana, T. G. & Ruel, M. 2006 CD117-positive cells and mast cells in adult human cardiac valves - observations and implications for the creation of bioengineered grafts. Cardiovasc. Pathol. 15, 36-40. (doi:10.1016/j.carpath.2005.08.005)
155. Wei, J. et al. 2004 Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell 5, 477-488. (doi:10.1016/S1535-6108(04)00116-3)
156. Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J. & Campbell, K. H. 1997 Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810-813. (doi:10.1038/385810a0)
157. Wobus, A. M. & Boheler, K. R. 2005 Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol. Rev. 85, 635-678. (doi:10.1152/physrev.00054.2003)
158. Yacoub, M., Suzuki, K. & Rosenthal, N. 2006 The future of regenerative therapy in patients with chronic heart failure. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl. 1), S133-S135. (doi:10.1038/ ncpcardio0401)
159. Zhang, S. C., Wernig, M., Duncan, I. D., Brustle, O. & Thomson, J. A. 2001 In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 19, 1129-1133. (doi:10.1038/nbt1201-1129)
160. Zhang, J., Qi, Y. F., Geng, B., Pan, C. S., Zhao, J., Chen, L., Yang, J., Chang, J. K. & Tang, C. S. 2005a Effect of relaxin on myocardial ischemia injury induced by isoproterenol. Peptides 26, 1632-1639. (doi:10.1016/j.peptides.2005.02.008)
161. Zhang, S. et al. 20056 Increased heme oxygenase-1 expression in infarcted rat hearts following human bone marrow mesenchymal cell transplantation. Microvasc. Res. 69, 64-70. (doi:10.1016/j.mvr. 2005.01.004)